Fifth Third Bancorp
MRNS

Fifth Third Bancorp’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Fifth Third Bancorp’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-115
Closed -$62 – 2628
2024
Q4 		$62 Hold
115
– – ﹤0.01% 2501
2024
Q3 		$202 Hold
115
– – ﹤0.01% 2524
2024
Q2 		$135 Hold
115
– – ﹤0.01% 2427
2024
Q1 		$1.04K Hold
115
– – ﹤0.01% 2268
2023
Q4 		$1.25K Hold
115
– – ﹤0.01% 2391
2023
Q3 		$926 Hold
115
– – ﹤0.01% 2466
2023
Q2 		$1.25K Buy
+115
New +$985 ﹤0.01% 2474

Fifth Third Bancorp's MRNS Position: Q1 2025 in Review

Fifth Third Bancorp sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 115 shares — an estimated $62 sold.

Fifth Third Bancorp first reported a position in MRNS in Q2 2023 and held it in 7 quarters. The position peaked at $1.25K in Q4 2023. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

  • Fifth Third Bancorp reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
  • Fifth Third Bancorp sold 115 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $62.
  • Fifth Third Bancorp first reported a position in Marinus Pharmaceuticals, Inc in Q2 2023 and held it in 7 quarters.
  • Fifth Third Bancorp's Marinus Pharmaceuticals, Inc position peaked at $1.25K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Fifth Third Bancorp's 13F filing for Q1 2025, filed 15 Apr 2025.